Immune monitoring of SARS-CoV-2-specific T cell and B cell responses in patients with multiple sclerosis treated with ocrelizumab.
Frontiers in immunology
View this publicationFrontiers in immunology
View this publicationHaemophilia : the official journal of the World Federation of Hemophilia
View this publicationBiomedicines
View this publicationLeukemia
View this publicationNature aging
View this publicationKidney medicine
View this publicationiScience
View this publicationJournal of clinical immunology
View this publicationThe Annals of thoracic surgery
View this publicationFrontiers in nuclear medicine (Lausanne, Switzerland)
View this publication